TP53 and neoplasm: All patients demonstrated at least one driver, such as TP53, BCORL1, CHD2, FAT3 and SPRY2 mutation in their common ancestral clone, followed by further subclonal acquisition of driver events as the tumour progressed in three patients (OVA_047, OVA_048 and OVA_378).